Clinical Trial

Behavioral Effects of Drugs

Study Description

Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)

This study will evaluate the behavioral effects of alcohol during maintenance on placebo, duloxetine, methylphenidate and duloxetine combined with methylphenidate using sophisticated human laboratory methods.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Alcohol

In each arm, subjects will receive doses of alcohol, designed to raise BALs to 0.015 and 0.03 g/dl.

Drug - Placebos

Subjects will receive placebo capsules.

Drug - Duloxetine

Subjects will receive duloxetine capsules.

Drug - Methylphenidate

Subjects will receive methylphenidate capsules.

Additional Information

Official Study Title

A Novel Drug Combination for Alcohol-Use Disorders: A Human Laboratory Study

Clinical Trial ID

NCT03575403

ParticipAid ID

dyPlnb